Basics |
Calidi Biotherapeutics, Inc.
|
IPO Date: |
November 1, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$12.76M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.08 | 6.44%
|
Avg Daily Range (30 D): |
$0.02 | 4.56%
|
Avg Daily Range (90 D): |
$0.05 | 6.26%
|
Institutional Daily Volume |
Avg Daily Volume: |
.71M |
Avg Daily Volume (30 D): |
.18M |
Avg Daily Volume (90 D): |
.77M |
Trade Size |
Avg Trade Size (Sh.): |
360 |
Avg Trade Size (Sh.) (30 D): |
501 |
Avg Trade Size (Sh.) (90 D): |
476 |
Institutional Trades |
Total Inst.Trades: |
0 |
Avg Inst. Trade: |
$M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
0 |
Market Closing Trades |
Avg Closing Trade: |
$M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.18
|
$.57
|
$-2.97
|
Diluted EPS
|
$-.18
|
$.57
|
$-2.97
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -5.06M
|
$ -4.15M
|
$ -22.21M
|
Operating Income / Loss
|
$ -5.06M
|
$ -4.03M
|
$ -21.78M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ .97M
|
$ 7.69M
|
$ 7.64M
|
PE Ratio
|
|
|
|
Splits |
Jul 15, 2024:
1:10
|
|